Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC)


Creative Commons License

Diaz-Garzon J., Fernandez Calle P., Minchinela J., Aarsand A. K., Bartlett W. A., Aslan B., ...Daha Fazla

CLINICA CHIMICA ACTA, cilt.495, ss.467-475, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 495
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.cca.2019.05.013
  • Dergi Adı: CLINICA CHIMICA ACTA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.467-475
  • Anahtar Kelimeler: Biological variation, Meta-analysis, Lipids, Cardiovascular risk, Analytical performance specifications, CONSENSUS STATEMENT, EUROPEAN FEDERATION, CLINICAL-CHEMISTRY
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Background: Biological variation (BV) data can be used to set analytical performance specifications (APS) for lipid assays. Poor performance will impact upon the efficacy of international guidelines for cardiovascular risk assessment (CVR) and relevant clinical decision limits. This systematic review applies the Biological Variation Data Critical Appraisal Checklist (BIVAC) to published studies of BV of CVR biomarkers enabling metanalysis of the data.